Prevalence of Heart Diseases Driving PTA Peripheral Drug Eluting Balloon Market


Published Date : Jun 05, 2017

ALBANY, New York, June 5, 2017 – MarketResearchReports.biz has announced the addition of a new report, exploring the prospects of the global PTA peripheral drug eluting balloon market, in its repository. The report, titled “Global PTA Peripheral Drug Eluting Balloon Market Research Report 2016,” aspires to serve as a reliable decision-making document for the stakeholders connected to the value chain of this market. It segments it on the PTA peripheral drug eluting balloon market on the basis of application, type, and region, takes historical data from 2011 and presents forecasts until 2021. From an evaluation of the leading vendors and noting the potential of different regions, the report also focuses on marketing strategies of the vendors and explores their production processes. 

Owing to the limitations of bare metal stents (BMS) and drug eluting stents (DES), drug eluting balloons (DEB) have gained demand in the recent past, which has proved its worth in treating artery diseases. Growing prevalence of peripheral artery diseases, diabetes, and obesity are also expected to augmenting the demand in the global PTA peripheral drug eluting balloon market. As per the findings of the American Heart Association, 10% to 40% in-stent restenosis still occurs in patients treated with stent implantation, which raises a need for higher number of trials to gain assurance regarding the effectiveness of drug eluting balloon. On the other hand, stringent regulatory guidelines, inadequate reimbursement for drug eluting balloons, and lack of awareness are some of the factors challenging the global PTA peripheral drug eluting balloon market. 

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/904038 

Based on type, the report segments the global PTA peripheral drug eluting balloon market into drug coating and paclitaxel, while on the basis of application, the market has been bifurcated into hospitals and others. Geographically, the report evaluates the potential of this market in several regions including North America, Europe, and Southeast Asia as well as country-wide markets of China, Japan, and India. 

As the market for PTA peripheral drug eluting balloon market is in nascent stage, a number of new vendors are expected to enter the market and technological advancements are expected. A number of leading companies operating in the global PTA peripheral drug eluting balloon market have been profiled in the report, such as B. Braun Melsungen AG, Medtronic plc, Cook Medical Inc., C. R. Bard, Inc., W. L. Gore. Associates, Inc., Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, Cordis Corporation, St. Jude Medical, Inc., and Maquet Holding B.V. Co. KG. For each of these companies, the report provides product specification, technology, production capacity, revenue, and market shares. 

The report also contains dedicated chapters on manufacturing process including raw materials, key suppliers, and price trend, industrial chain and downstream buyers, strategies of distributors and traders to reach the end-users such as hospitals and medical outlets, and other factor reports.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz